Special Issue "Virus Immune Escape and Host Immune System"
Deadline for manuscript submissions: closed (31 August 2020).
Interests: virus-host interactions; molecular virology; innate immune signaling pathways; molecular biology; microbiology; cell biology; immunology; oncolytic virotherapy and immunotherapy; cancer biology; development of therapeutic proteins
Special Issues and Collections in MDPI journals
Virus-host interaction studies is a fascinating area of research. Hosts have numerous counter-measures against virus infections, viruses, on the other hand, have co-evolved to defend the host anti-viral innate and adaptive immune responses. In their natural host, viruses have learned to co-exist with the hosts; however, the same virus could cause severe disease and pathogenesis when infecting a new host. Such incidence might cause a severe burden on society. Recent discoveries made significant progress in finding novel virus-host interactions, more to be discovered and learned in terms of the development of vaccines against new emerging viruses. The understanding of virus-host interaction is particularly important for the recent developments in the use of viruses as potential therapeutics such as oncolytic viruses, gene therapy vectors, cancer vaccines, and treatment of emerging genetic and infectious diseases.
This special issue focuses on the recent findings of viral immune evasion strategies and host counter-measures to prevent virus infection. The goal is to enhance our understanding of the complex and fascinating interaction between the virus and host defense. Understanding virus-host interactions will eventually help to develop effective vaccines and therapeutics against life-threatening viral infections. This special issue invites contribution to these areas of research.
Prof. Masmudur M. Rahman
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Virus-host interactions
- Immune evasion
- Innate immunity Adaptive immunity
- Host anti-viral defenses
- Viral pathogenicity Vaccines
- Immunomodulatory proteins